IFF sells flavor specialty ingredients business to Exponent for $220m
International Flavors & Fragrances Inc. (IFF) has announced the completion of its divestiture of the Flavor Specialty Ingredients (FSI) business to Exponent, a UK-based private ... Read More
International Flavors & Fragrances to sell Savory Solutions to PAI Partners
US-based International Flavors & Fragrances (IFF) has agreed to sell Savory Solutions Group to French private equity firm PAI Partners for an enterprise value of ... Read More
Merck secures EC approval for Keytruda in combination therapy for lung cancer
Merck has achieved a significant milestone by obtaining approval from the European Commission (EC) for its cancer immunotherapy, Keytruda (pembrolizumab), to be used in combination ... Read More